Beatriz Zazueta

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Subcutaneous Tocilizumab Versus Placebo in Combination With Disease‐Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis

Alan Kivitz, Ewa Olech, Michael Borofsky et al. · Arthritis Care & Research · 2014 · 145 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

An acute remission of Reiter's syndrome in male patients treated with bromocriptine.

Guadalupe Bravo, Beatriz Zazueta, C Lavalle · PubMed · 1992 · 33 citations

Medicine, Internal Medicine, Pharmacotherapy +8

Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis

Alan Kivitz, Ewa Olech, Michael Borofsky et al. · The Journal of Rheumatology · 2017 · 16 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17